![Robert A. Millman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert A. Millman
Directeur/Membre du Conseil chez
Abcuro, Inc.
Profil
Mr. Robert A. Millman is a Managing Director at MPM Capital LP and Co-Founder at iPierian, Inc. He joined MPM Capital in 2008.
Mr. Millman was previously employed as Chief Intellectual Property Counsel by Alnylam Pharmaceuticals, Inc., a Principal by Celera Genomics Group, an Associate by Morrison & Foerster LLP, a Principal by Infinity Pharmaceuticals, Inc., a Principal by Millennium Pharmaceuticals, Inc., and a Principal by Sterne, Kessler, Goldstein & Fox PLLC.
Mr. Millman received his JD degree from the Washington College of Law at The American University, an MS degree in Genetics from Washington State University and a B.S.
degree in Biochemistry from the University of California, Riverside.
Postes actifs de Robert A. Millman
| Sociétés | Poste | Début |
|---|---|---|
Abcuro, Inc.
 Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Directeur/Membre du Conseil | - |
Nayan Therapeutics, Inc.
 Nayan Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert A. Millman
| Sociétés | Poste | Fin |
|---|---|---|
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | 11/04/2022 |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
CytoSolv, Inc.
 CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology Develops proprietary technology to address wound healing | President | - |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Fondateur | - |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | President | - |
Formation de Robert A. Millman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sterne, Kessler, Goldstein & Fox PLLC
 Sterne, Kessler, Goldstein & Fox PLLC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
CytoSolv, Inc.
CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology Develops proprietary technology to address wound healing | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
American University Washington College of Law
 American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
Abcuro, Inc.
Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Develops bio therapeutics for treatment of autoimmunity and cancer | Commercial Services |
Nayan Therapeutics, Inc.
Nayan Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
